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Interest in the study of marine sponges and their associated microbiome has
increased both for ecological reasons and for their great biotechnological potential.
In this work, heterotrophic bacteria associated with three specimens of the marine
sponge Erylus deficiens, were isolated in pure culture, phylogenetically identified
and screened for antimicrobial activity. The isolation of bacteria after an enrichment
treatment in heterotrophic medium revealed diversity in bacterial composition with only
Pseudoalteromonas being shared by two specimens. Of the 83 selected isolates, 58%
belong to Proteobacteria, 23% to Actinobacteria and 19% to Firmicutes. Diffusion agar
assays for bioactivity screening against four bacterial strains and one yeast, revealed that
a high number of the isolated bacteria (68.7%) were active, particularly against Candida
albicans and Vibrio anguillarum. Pseudoalteromonas,Microbacterium, and Proteuswere
the most bioactive genera. After this preliminary screening, the bioactive strains were
further evaluated in liquid assays against C. albicans, Bacillus subtilis and Escherichia
coli. Filtered culture medium and acetone extracts from three and 5 days-old cultures
were assayed. High antifungal activity against C. albicans in both aqueous and acetone
extracts as well as absence of activity against B. subtilis were confirmed. Higher levels of
activity were obtained with the aqueous extracts when compared to the acetone extracts
and differences were also observed between the 3 and 5 day-old extracts. Furthermore,
a low number of active strains was observed against E. coli. Potential presence of type-I
polyketide synthases (PKS-I) and non-ribosomal peptide synthetases (NRPSs) genes
were detected in 17 and 30 isolates, respectively. The high levels of bioactivity and the
likely presence of associated genes suggest that Erylus deficiens bacteria are potential
sources of novel marine bioactive compounds.
Keywords: sponge associated heterotrophic bacteria, Erylus deficiens, bioactivity screening assay, PKS-I and
NRPS genes, Candida albicans
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Introduction
Marine sponges (Phylum Porifera) are sessile ﬁlter-feeding
organisms and represent a signiﬁcant component of benthic
communities’ worldwide (Sarà and Vacelet, 1973). They har-
bor a large community of diverse microorganisms, represent-
ing up to 50–60% of the sponge biomass (Thomas et al., 2010),
which develop symbiotic relationships essential to their biology.
Sponges have been the focus of many studies as they have proved
to be a rich source of biologically active secondary metabolites.
These compounds may serve as a defense strategy to escape
from predators, thus playing a crucial role in sponge survival
in the marine ecosystem (Thakur and Müller, 2004). Since the
discovery of spongothymidine and spongouridine in the early
50’s (Bergmann and Feeney, 1950, 1951), a great number of bio-
logically active compounds were isolated from marine sponges
and their associated microorganisms (Taylor et al., 2007; Thomas
et al., 2010). About 300 novel compounds were reported in 2011
from the phylum Porifera (Blunt et al., 2013) and more sponge-
derived compounds are subjected to clinical and preclinical tri-
als than from any other marine phylum (Martins et al., 2014).
The chemical diversity of sponge-derived products is remark-
able and their biological activity ranges from anti-inﬂammatory,
antitumour, immuno- or neurosuppressive, antiviral, antimalar-
ial, antibiotic to antifouling (Imhoﬀ et al., 2011). However, many
of the bioactive compounds found in sponges are, in fact, pro-
duced by their associated microbial communities (Wang, 2006;
Khan et al., 2014). This is the case, for instance, of the peptide
thiocoraline, produced by a sponge-associated Micromonospora
species (Romero et al., 1997) and the cytotoxic and antibacterial
tetrabromodiphenyl ethers produced by a Vibrio spp. associated
with the sponge Dysidea sp. (Elyakov et al., 1991). This micro-
bial community represents a treasure trove of novel molecules
for marine biotechnology. Due to the increasing resistance of
bacteria against the common antibiotics there is still a press-
ing need to ﬁnd new drugs (Bull and Stach, 2007; Kumarasamy
et al., 2010). By the end of 2008, about 3000 natural prod-
ucts had been identiﬁed from marine microorganisms (Laatsch,
2008). The most relevant phyla of bacterial producers of new
compounds are Actinobacteria (40%), Cyanobacteria (33%), Pro-
teobacteria (12%), and Firmicutes and Bacteroidetes (5% each)
(Williams, 2009). In addition to these, archaea, fungi, unicellu-
lar algae and other bacterial phyla namely Acidobacteria, Chlo-
roﬂexi, Deinococcus-Thermus, Firmicutes, Gemmatimonadetes,
Nitrospira, Planctomycetes, Poribacteria, Spirochaetes, and Verru-
comicrobia, are also present in the sponge microbial community
as revealed mainly by culture-independent molecular methods
(Taylor et al., 2007).
In a genomic era, it is easy to assess by molecular methods
the bacterial potential for the production of bioactive molecules.
These natural bioactive secondary metabolites can be the result
of the activity of non-ribosomal peptide synthetases (NRPSs)
and polyketide synthases (PKSs) that are large multi-modular,
multi-domain enzymes. The minimal set of domains that have
to be present in these biosynthetic pathways are ketosynthase
(KS), acyltransferase (AT) and acyl carrier proteins in PKSs
(Khan et al., 2014) and adenylation (A), condensation (C)
and peptidyl carrier proteins (PCPs) for peptide elongation in
NRPSs (Jenke-Kodama and Dittmann, 2009). In addition to
the synthesis of these deﬁned domains, optional domains can
also be produced like ketoreductase. The intra and inter vari-
ability of the enzymatic modules codiﬁed by PKS and NRPS
genes results in the production of diverse bioactive compounds.
Antibiotic molecules such erythromycin, tetracycline and gly-
copeptides of the vancomycin family were reported to have
origin in PKS and NRPS productions (Fischbach and Walsh,
2006). In fact, many of the complex polyketides isolated from
sponges are the most promising compounds with pharmacologi-
cal application (Hochmuth and Piel, 2009). Therefore, the search
for the genes responsible for the expression of these enzymes
is indicative of the biotechnological potential of a speciﬁc
organism.
Themarine sponge genus Erylus, Gray, 1867, contains approx-
imately 70 species and is known to inhabit the Mediterranean
Sea, and the Atlantic and Paciﬁc Oceans (Adams and Hooper,
2001). Species of this genus have been reported to possess char-
acteristic bioactive glycosides named, according to their aglycone
skeleton, erylosides or erylusamines (Kalinin et al., 2012). Some
of these glycolipids have been shown to inhibit tumor cells, fungi,
bacteria, viruses including the human immunodeﬁciency virus
(HIV), neuraminidase, interleukin-6, thrombin receptor antag-
onist, and in vitro human platelet aggregation (Carmely et al.,
1989; Fusetani et al., 1993; Gulavita et al., 1994; Sata et al., 1994;
Stead et al., 2000; Kubanek and Fenical, 2001; Shin et al., 2001;
Takada et al., 2002; Van Altena et al., 2003; Fouad et al., 2004;
Sandler et al., 2005; Okada et al., 2006; Aﬁyatullov et al., 2007;
Antonov et al., 2007). Furthermore, Erylus spp. are well known
producers of oligoglycosides with antifeedant activity involved
in chemical defenses of sponges against predatory ﬁsh (Kubanek
et al., 2000; Kubanek and Fenical, 2001; Antonov et al., 2011) and
with larvicidal activity (Carballeira and Negrón, 1991). Crude
extracts of Erylus deﬁciens from the Portuguese coast were found
to possess indoleamine 2,3-dioxygenase (IDO) inhibitory activ-
ity (Gaspar et al., 2012). This enzyme plays a fundamental role in
the kynurenine pathway, one of the major tryptophan catabolism
routes with implications in cancer and in CNS disorders like
Alzheimer’s disease and cerebral malaria (Chen and Guillemin,
2009). The bioactive potential of bacteria associated with Ery-
lus discophorus was evidenced by Graça et al. (2013). The work
showed that 31% of the isolated bacteria were able to produce
antimicrobial metabolites being this the only study performed
with bacteria associated with the Erylus sponges. This lack of
results associated with the low yield of metabolites normally orig-
inated from marine sponges, together with the importance of
obtaining new bioactive bacteria to avoid the undesired exploita-
tion of natural sponges, lead us to assess in three specimens of E.
deﬁciens collected in the Gorringe Bank, an isolated seamount in
the Atlantic, the potential of heterotrophic culturable bacteria as
actual producers of antimicrobial compounds by screening and
molecular assays. As glycolipids from these sponges are already
being studied by others, NRPS and PKS appeared as good gene
targets for the search of new potential bioactivities.
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Materials and Methods
Sponge Sampling and Identification
Three specimens of E. deﬁciens Topsent, 1927 (Demospon-
giae, Astrophorida, Geodiidae) were collected by scuba diving
at approximately 38m depth on Gettysburg (specimens #66 and
#91—lat. 36◦ 31′ 10′′ N, long. 11◦ 34′ 10′′ W) and Ormonde
(specimen #118—lat. 36◦ 42′ 70′′ N, 11◦ 09′ 70′′ W) Peaks, in
the course of LusoExpedição Olympus 2008 to the Gorringe
Bank, a large seamount located 150 Km oﬀ the southwest coast
of Portugal. The samples were placed individually in ziploc R©
plastic bags and then carried to the laboratory for identiﬁcation
and microbial isolation. Voucher samples were preserved in 90%
ethanol for taxonomic identiﬁcation and deposited in the Biology
Department’s zoological collection of the University of the Azores
(collection DBUA.Por). Specimens were identiﬁed using gen-
eral external and internal morphological characters analysis, i.e.,
shape, type, size and arrangement of skeletal structures (spicules)
following the Systema Porifera classiﬁcation system (Hooper and
Van Soest, 2002). This species was previously reported in this
seamount and identiﬁed as Erylus sp. (Xavier and Van Soest,
2007) and further examination of additional samples, including
specimens from Madeira Island, the type-locality of E. deﬁciens,
enabled its identiﬁcation to species level.
Heterotrophic Bacterial Isolation
Fragments of sponge tissues were placed under aseptic condi-
tions in sterile Erlenmeyers containing M514 medium (Bacto-
peptone (Difco) 5 g/L; yeast Extract (Oxoid) 1 g/L and sea salts
(Red Sea R©) 36 g/L). This enrichment was performed to pro-
mote faster growing and abundant heterotrophic bacteria. When
noticeable bacterial growth occurred, usually after 1 week with-
out stirring, several dilutions (10−1, 10−6, and 10−12) were
prepared and, 100μL of each, spread in several solid marine
media prepared with 0.2μm ﬁltered natural seawater and 1.8%
agar: modiﬁed M13 (Lage and Bondoso, 2011), PYGV (0.025%
peptone, 0.025% yeast extract, 0.025% glucose, 10mL.L−1 vita-
min solution n◦6, 20mL.L−1 Hutner’s basal salts (Cohen-Bazire
et al., 1957), Marine Agar (MA - Difco), M17 (Difco), Glycerol
Asparagine (1% glycerol, 0.1% L-asparagine, 0.1% K2HPO4), M4
(Zhang et al., 2006). Cultures were incubated in the dark at 26◦C.
Growth was monitored daily and distinct colony morphotypes
were transferred to fresh medium for isolation. Pure bacterial
cultures were cryopreserved in seawater supplemented with 20%
glycerol at−80◦C.
Molecular Identification of Isolates
Isolates were identiﬁed by 16S rRNA gene sequence analysis after
ampliﬁcation with the primers 27f and 1492r (Lane, 1991). The
PCR was carried out as described by Bondoso et al. (2011), using,
as template, material from a single colony or genomic DNA
extracted with the Bacterial DNA Isolation Kit (Omega), accord-
ing to themanufacturer’ instructions. PCR products were directly
sequenced at Macrogen Europe (www.Macrogen.com).
The obtained 16S rRNA gene sequences were processed with
the Sequencing Analysis 5.2 (Applied Biosystems) and assembled
with Vector NTI Advance™ 10.3. The resulting 16S rRNA gene
sequences were then blasted on SeqMatch (Ribossomal Database
Project) (Cole et al., 2014) against the nucleotide database of Gen-
Bank (NCBI) and the closest neighbors were downloaded. The
sequences were corrected manually using the alignment gener-
ated. Subsquently, sequences with 818 bp were used for molec-
ular evolutionary analyses in MEGA version 5.2 (Tamura et al.,
2011). A ﬁnal maximum likelihood (ML) phylogenetic tree was
generated applying General Time Reversible model and Gamma
distributed with Invariant sites (G+I). Validation of reproducibil-
ity of the branching patterns was made by bootstrap based on
1000 resamplings. Pairwise sequence similarities based on Jukes-
Cantor model were calculated in MEGA. Alignment gaps and
missing data were not included in the calculations. Diﬀerent phy-
lotypes were considered based on a 97% 16S rRNA gene threshold
(Stackebrandt and Goebel, 1994). The sequences of the isolated
bacteria used in this study were deposited in GenBank with the
serial accession numbers KP120772- KP120854.
Bioactivity of the Bacterial Isolates
To assess the antimicrobial bioactivity of the sponge-isolated bac-
teria, designated hereunder as test bacteria, a simple co-culture
agar diﬀusion assay (pre-screening) was performed against a
panel of target organisms. This panel was constituted by Gram
negative and positive bacteria commonly used in bioactiv-
ity bioassays, a relevant environmental species and a human
pathogenic yeast. Thus, the bioactivity against four bacterial
strains (Bacillus subtilis ATCC 6633, B. cereus FCUP collection,
Escherichia coliATCC 25922 and the ﬁsh pathogen Vibrio anguil-
larum FCUP collection) and a yeast (clinical isolate of Can-
dida albicans) was evaluated. The agar diﬀusion assay was per-
formed in MAmedium, solidiﬁed with 1.4% agar as this medium
allowed the simultaneous growth of the test bacteria and the tar-
get microorganisms. The test bacteria were heavily inoculated on
half a Petri dish containing MAmedium and incubated vertically
to favor the diﬀusion of the metabolites to the non-inoculated
part of the medium, at 26◦C for 48 h. By this time, the fast grow-
ing test bacteria attained the stationary growth phase. Subse-
quently, the ﬁve target microorganisms were inoculated on the
other half by streaking a line perpendicularly to the test bacteria
and parallel to each other. The cultures were grown at 37 ◦C in the
same position as described before. The presence of growth inhi-
bition was observed after 24 h. Target organisms grown in MA
medium were used as controls.
To conﬁrm the positive results obtained with the prelimi-
nary assay, a liquid screening assay was performed based on
Graça et al. (2013). Of the 57 bacteria that showed antimi-
crobial activity only 48 were assayed as nine lost viability
(#91_37, #91_40, #91_43, #91_45, #118_14, #118_23, #118_27,
#118_33, and #118_39). The bacteria were grown in MB for 3
and 5 days at 25◦C and 200 r.p.m. At days 3 and 5, an aliquot
of 2mL of the culture was centrifuged and the supernatant was
0.22μm ﬁltered and stored at−20◦C—aqueous extract. Another
aliquot of 2mL of culture wasmixed with 1.8mL acetone +0.2mL
DMSO, incubated for 1 h after which the upper phase was col-
lected and stored at −20◦C—acetone extract. In 96-well plates,
duplicates of 10μL of each extract were assayed against 90μL of
each target microorganism cultivated in LBmedium (≈ 2.5×105
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CFUs/mL). Additionally, 100μL of each target microorganism
were cultivated to allow the assessment of the total growth of
the microorganisms. As positive controls, amphotericin B (0.19;
0.39; 0.78; and 1.56μg/ml) and rifampicin (62.5; 125; 250; and
500mg/ml) were used against C. albicans and E. coli, respec-
tively. LB medium was used as negative control. In order to
assess the possible interference of the solvents acetone+DMSO
present in the extracts, both C. albicans and E. coli were grown
in the presence of the same concentration used for the bioac-
tivity assays. As no signiﬁcant variation was induced by the
solvents used to obtain the extracts, these values will not be
considered in the calculation of bioactivities. The plates were
incubated at 37◦C for 24 h at 250 r.p.m. The optical density
(OD) of the cultures was measured at 600 nm in a Multiskan
GO plate reader (Thermo Scientiﬁc). The growth of the tar-
get microorganisms (%) was calculated by the following equa-
tion: (ODcultures with extract – ODLB medium)/ODpositive control×100.
Variability in the positive controls was of about 10%, reason
why only growth inhibitions of equal or more than 25% were
considered.
Search for PKS-I and NRPS Genes
The presence of genes involved in the production of secondary
metabolites was screened in all the isolates obtained. The degen-
erate primers MDPQQRf (5′-RTRGAYCCNCAGCAICG-3′) and
HGTGTr (5′-VGTNCCNGTGCCRTG-3′) (Kim et al., 2005)
were used to amplify the β-ketosynthase (KS) domain fragment
within the Type I polyketide synthase genes PKS-I. For the
ampliﬁcation of NRPS, primers MTF2 [5′- GCNGG(C/T)GG(C/
T)GCNTA(C/T)GTNCC-3′(AGGAYVP, core motif I)] and MTR
[5′- CCNCG(AGT)AT(TC)TTNAC(T/C)TG-3′(QVKIRG, core
motif V)] (Neilan et al., 1999) were used. The PCR mixture
contained 1x PCR buﬀer, 0.8 units of Go Taq DNA Polymerase
(Promega), 0.2mM of each dNTPs, 0.1μM of each primer and
1μL genomic DNA as template. The PCR proﬁle consisted of
an initial denaturing step of 5min at 95◦C, 11 cycles of 1min at
95◦C, 30 s at 60◦C and 1min at 72◦C, with the annealing tem-
perature reduced by 2◦C per cycle, followed by 30 cycles of 95◦C
for 1min, 40◦C for 30 s and 72◦C for 1min with a ﬁnal extension
of 10min at 72◦C (Kim et al., 2005). The PCR was carried out in
a MyCycler™ Thermo Cycler (Bio-Rad) and the amplicons were
visualized in a Roti-Safe (Roth) stained 1.2% agarose gel.
Results
16S rRNA Gene Analysis Identification
A total of 83 isolates were selected after enrichment procedure
from the three specimens of E. deﬁciens. All assayed media
allowed the isolation of bacterial strains although marine agar
was the medium that provided the highest number of isolates and
broad diversity from the three sponges. Curiously, M17 medium
that is designed to grow fastidious lactic streptococci, allowed the
growth of several Firmicutes and Actinobacteria. The majority of
the strains obtained in this study after the enrichment belong
to Proteobacteria (58%), followed by Actinobacteria (23%) and
Firmicutes (19%) (Table 1; Figure 1). Within the Proteobacteria,
the most abundant class was the Gammaproteobacteria with 46
isolates and the genus Pseudoalteromonas (27 isolates). Within
the Actinobacteria, the genusMicrobacterium was represented by
13 isolates. Of the selected strains and based on a 16S rRNA gene
97% threshold, 10 diﬀerent phylotypes were from sponge #91,
ﬁve phylotypes from sponge #118 and only one phylotype from
sponge #66.
Bioactivity of the Bacterial Isolates
Through the co-culture diﬀusion pre-screening assay, 68.7% (57
bacteria) of the isolated bacteria showed antimicrobial activity
against one or more of the target microorganisms tested. The
highest number of positive hits were found in Gammaproteobac-
teria (63.2%) and Actinobacteria (21.1%) followed by Firmicutes
(14.0%) and Alphaproteobacteria (1.8%). Of the thirteen genera
showing antimicrobial bioactivity, Pseudoalteromonas (42.1%),
Microbacterium (14.0%) and Proteus (12.3%) presented the high-
est positive hits. The analysis of bioactivity by test bacteria
(Table 1) revealed a high number of strains with antifungal
activity against C. albicans (87.7%—50 bacteria) and antibiotic
against V. anguillarum (63.2%—36 bacteria) and, in lower num-
ber, against E. coli (17.5%—10 bacteria) and B. subtilis (3.5%—2
bacteria). None of the isolates produced eﬀective bioactive com-
pounds against the Gram positive B. cereus. Some bioactive bacte-
ria were able to produce secondary bioactive metabolites against
two ormore target microorganisms.Microbacteriumwas the only
genus able to produce bioactive compounds eﬀective against B.
subtilis (Figure 2).
In order to conﬁrm the positive results obtained in the pre-
liminary assay, a liquid screening assay was performed which
allowed a more precise evaluation of the bioactivities. In this
screening, 92% (45 bacteria) of the bacteria assayed showed
bioactivity. Again, more bacteria showed bioactivity against C.
albicans (80%—36 bacteria), only 4% (2 bacteria) showed activ-
ity against E. coli and 16% (7 bacteria) against both. A total of
86.6% bacteria (n = 39) showed activity in their aqueous extracts
(87% against C. albicans and 13% against both C. albicans and
E. coli) while only 62.2% bacteria (n = 28) showed bioactivity
in acetone extracts. The levels of inhibition obtained (maximum
value and median) with the aqueous extracts (3 and 5 days) were
higher than the ones with acetone (Figure 3). The analysis of the
bioactive extracts also showed higher levels of inhibition against
C. albicans than against E. coli in which inhibition levels were very
low (Figure 4). Furthermore, it was possible to verify in the assays
against C. albicans that the 3 days acetone extracts were less eﬀec-
tive than the aqueous and 5 days extracts. Although the median
of 5 days aqueous extracts was not so high comparatively to the
3 days aqueous or the 5 days acetone extracts, the maximum
value as well as the number of bioactive extracts were higher. No
activity was obtained with 3 days aqueous extracts against E. coli.
Search for PKS-I and NRPS Genes
The β-ketosynthase domain fragment within the Type I polyke-
tide synthase genes PKS-I was potentially ampliﬁed from 17 E.
deﬁciens isolates (Table 1). Ten bacteria phylogenetically aﬃl-
iated to Pseudoalteromonas from sponges #91 and #66, four
to Microbacterium and two to Rhodococcus from sponge #91
and one to Proteus from sponge #118 ampliﬁed probable
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PKS-I sequences. The potential ampliﬁcation of the motifs I
and V of non-peptide synthetase adenylate-forming enzymes
was observed in thirty strains (Table 1)—10 Pseudoalteromonas
from sponge #66, four Enterococcus from sponge #118, three
Paenibacillus from sponge #91, three Psycrobacter from sponge
#118, two Bacillus from sponge #118, two Rhodococcus from
sponge #91 and one Dermacoccus, one Microbacterium, one
Brevundimonas and one Paracoccus, from sponge #91 and one
FIGURE 1 | Continued
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FIGURE 1 | Phylogenetic 16S rRNA gene tree generated by
maximum-likelihood analysis based in General Time Reversible
model and Gamma distributed with Invariant sites (G+I)
indicating the relationship of the heterotrophic bacteria isolated
from three E. deficiens specimens. Thermatoga maritima was used
as outgroup. Bar – 0.05 substitutions per 100 nucleotides. *Presence
of NRPS genes; **Presence of PKS-I genes; ***Presence of both
genes.
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FIGURE 2 | Relation between the hits of bioactive genera and the target organisms studied in the preliminary screening.
Citrobacter and Proteus from sponge #118. A relatively high
number of the bioactive isolates ampliﬁed for the searched genes
and some for both genes. However, other genes should be behind
the detected bioactivity in non-amplifying isolates.
Discussion
Since one of the most eﬀective methods used in the discovery
of natural products is the cultivation of new microbial strains
which may represent novel important chemotypes (Fenical and
Jensen, 2006; Haber and Ilan, 2013), our prime goal was to obtain
bacterial isolates for screening antimicrobial activities.
The isolation of bacterial strains from E. deﬁciens after an
enrichment procedure allowed the selection of a high number
of fast growing heterotrophic bacteria, mainly belonging to Pro-
teobacteria. Similarly, Kamke et al. (2010) also observed that
one of the most abundant taxon in both libraries of Ancorina
alata and Polymastia sp. was the class Gammaproteobacteria.
Proteobacteria was the most abundant phylum in the phyloge-
netic distribution of sponge-isolated bacteria (Webster and Tay-
lor, 2012) namely from another Erylus species, E. discophorus
(Graça et al., 2013). Furthermore, species of Firmicutes and Acti-
nobacteria, both phyla commonly present in sponges (Webster
and Taylor, 2012), were also obtained.
Almost no bacterium was common among the three spec-
imens as evidenced by the analysis of the 16S rRNA gene
sequences (Figure 1). A possible explanation for this result may
be the use of sponge portions from diﬀerent structural parts
of the sponge body that are known to be inhabited by diﬀer-
ent microbial communities (Thiel et al., 2006). The group of
Pseudoalteromonas was the only one shared by specimens #91
and #66 which could be explained by sponges sampling site’s
proximity. This genus is often isolated frommarine macroorgan-
isms like sponges (Ivanova et al., 2002; Lau et al., 2005).
Several of the bioactive genera isolated in this study have
been described as possessing antimicrobial activity. Pseudoal-
teromonas is a well-known bioactive compounds producer
Hentschel et al., 2001; Bowman, 2007; Thomas et al., 2008; Siva-
subramanian et al., 2011; Chen et al., 2012b; Vynne et al., 2012
as well as Bacillus (Bernal et al., 2002; Bhatta and Kapadnis, 2010;
Jamal andMudarris, 2010; Kamat and Kerkar, 2011; Kumar et al.,
2012; Graça et al., 2013). Bioactivity has also been found in Pseu-
domonas (Kumar et al., 2005; Isnansetyo and Kamei, 2009; Graça
et al., 2013), Enterococcus faecalis (Gútiez et al., 2013), Paenibacil-
lus (Chung et al., 2000; Tupinambá et al., 2008; Wen et al., 2011;
Graça et al., 2013) and Microbacterium (Lang et al., 2004; Graça
et al., 2013). Antibacterial activity produced by Psychrobacter has
been previously found (Kanagasabhapathy et al., 2008; Kennedy
et al., 2009; Rojas et al., 2009; Flemer et al., 2011) but not anti-
fungal activity. Rhodococcus (Chiba et al., 1999; Riedlinger et al.,
2004; Lo Giudice et al., 2007; Hong et al., 2009; Abdelmohsen
et al., 2010; Abdelmohsen et al., 2014) and Paracoccus (Lo Giu-
dice et al., 2007; Deng et al., 2011) showed antimicrobial activ-
ity.Dermacoccuswas shown to produce antimicrobial, antitumor
and antiprotozoal activity (Pospísil et al., 1998; Goodfellow and
Fiedler, 2010). No antimicrobial activity has been detected in the
generaCellulomonas and Proteus. Okada et al. (2006) veriﬁed that
the marine sponge Erylus placenta collected oﬀ Hachijo Island
exhibited a broad spectrum of activity against several strains of
yeasts and a fungus. This result is in agreement with the high
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FIGURE 3 | Comparison of the levels of inhibition (higher than 25%)
between the aqueous and the acetone extracts from Erylus deficiens
isolates in the liquid assays. The numbers above each box represent the
number of bioactive extracts.
levels of bioactivity againstC. albicans obtained in our E. deﬁciens
isolates.
The two preliminary and liquid assays allowed the conﬁrma-
tion of a great number of positive bacterial hits againstC. albicans
(72%—36 bacteria) but dissimilar results were obtained for E.
coli and B. subtilis. In fact, these assays were not always coin-
cident in the bioactivities obtained (Table 1), which could be
due to diﬀerences in the cultivation (solid vs. liquid) and the
extraction methods as previously observed (Bode et al., 2002;
Graça et al., 2013; Haber and Ilan, 2013). In the diﬀusion assay
there is always a potential problem with the diﬀusion of the
bioactive molecules as well as the establishment of a concentra-
tion gradient. However, celerity and simplicity favor the use of
this qualitative method (Valgas et al., 2007). Additionally, inter-
action between target and test microorganisms could induce a
quorum-sensing response with antimicrobial production (Haber
and Ilan, 2013). The assays using liquid broths have the advantage
of being quantitative, simple, rapid, reproducible, and inexpen-
sive and can be performed in a high throughput way. Further-
more, this method facilitates the upscale of the process in the case
of a positive hit (avoiding constrains caused by the use of solid
media).
The aqueous extracts presented higher bioactivities than the
organic ones. This may be indicative of a hydrophilic nature
of the bioactive molecules which could be proteins or sugars.
With the acetone extraction, proteins would be precipitated and
removed from the extract that could justify the decrease in
bioactivity.
The genomic screening of bioactive potential is a valuable
complement to the search for new bioactive molecules. The pres-
ence of PKS-I or NRPS genes was conﬁrmed in some posi-
tive antimicrobial bacteria but non-bioactive bacteria also pos-
sessed these genes. This may indicate their ability to produce
compounds with diﬀerent types of activities like against other
FIGURE 4 | Levels of inhibition (higher than 25%) of 3 and 5 days and
aqueous (aqu) and acetone (acet) extracts from Erylus deficiens
isolates against C. albicans (Ca) and E. coli (Ec). No result is shown for
aqueous, 3 days extracts against E. coli due to the absence of inhibition. The
numbers above each box represent the number of bioactive extracts.
bacteria or even anticancer (Davidson et al., 2001). The PKS
genes were previously found in the genera Pseudoalteromonas
(Kennedy et al., 2009; Zhu et al., 2009; Chau et al., 2012) and
Rhodococcus (Ayuso-Sacido and Genilloud, 2005; Abdelmohsen
et al., 2014). However, to our knowledge, the present study is the
ﬁrst to detect PKS genes in the genera Proteus and Microbac-
terium. Regarding the NRPS genes, they have been previously
detected in Pseudoalteromonas (Zhu et al., 2009; Chen et al.,
2012a), Enterococcus (in the database: Biocyc.org1), Paenibacil-
lus (Wu et al., 2011), Bacillus (Luo et al., 2014), Rhodococ-
cus (Bosello et al., 2013), Dermacoccus (Pathom-aree et al.,
2006), Microbacterium (Wu et al., 2012), Citrobacter (Siezen
and Khayatt, 2008), and Proteus (Himpsl et al., 2010) but
as far as perceived not in Psycrobacter, Brevundimonas and
Paracoccus.
Of the conﬁrmed bacteria that showed bioactivity against C.
albicans, strain #91_11 belonging to the class Gammaproteobac-
teria is probably a novel species of Pseudoalteromonas based on
the 16S rRNA gene (96.2% to P. tetraodonis, Figure 1). Further-
more, and based on the same gene similarity, other isolates with
non-conﬁrmed bioactivity (#66_1, #91_27, and #118_39) are also
potential new taxa of Gammaproteobacteria.
Our results show a great antifungal potential of bacteria asso-
ciated with E. deﬁciens. Curiously, in a previous work with
heterotrophic bacteria of another Erylus species, E. discophorus
(Graça et al., 2013), no antifungal activity was obtained. The
bioactivity found was essentially against Bacillus subtilis which
was almost absent in this work. Both works evidence for the
production of bioactive compounds of bacteria associated with
1Biocyc.org.http://www.biocyc.org/EFAE749506-HMP/NEW-IMAGE?object=D-
Phenylalanyl-Acps.
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Erylus sponges which should be further studied regarding iso-
lation and identiﬁcation of the molecules accountable for the
bioactivity.
Conclusions
The isolation and phylogenetic analyses of the culturable fraction
of the bacterial community isolated from E. deﬁciens revealed
a biodiversity with putative new taxa of Gammaproteobacteria
that should be further studied regarding genome analysis and
taxonomic characterization.
A great number of Erylus isolates were found to produce
antibacterial and high antifungal bioactivity against pathogenic
and environmental strains. As far as we know, this is the ﬁrst
report of antimicrobial production in the genera Cellulomonas
and Proteus. Furthermore, PKS and NRPS genes are poten-
tially associated with several Erylus isolates, namely the genera
Proteus, Microbacterium for PKS-I and Psycrobacter, Brevundi-
monas, and Paracoccus for NRPS for which these genes have
not been previously described. Our results showed the biotech-
nological potential of bacterial diversity associated with E. deﬁ-
ciens, inspiring further studies for the search of new leading
compounds.
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